Recursion Initiates Two Additional Clinical Trials For a Tot

/PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced the...

Related Keywords

France , Germany , Salt Lake City , Utah , United States , United Kingdom , Italy , Montreal , Quebec , Canada , Toronto , Ontario , Spain , Chris Gibson , Shafique Virani , Niloy Jewel Samadder , Office Of Individualized Precision Medicine , Enterprise Co , European Commission , Drug Administration , Mayo Clinic Comprehensive Cancer Center , Familial Adenomatous Polyposis , Fast Track , Orphan Drug , Mayo Clinic , Enterprise Co Director , Precision Medicine , Mayo Clinic Comprehensive Cancer , Clostridium Difficile Infection , Chief Business Officer , Interim Chief Medical Officer , San Francisco Bay , Recursion ,